Back
Incyte Stock Predictions
Sponsored
INCY
Sponsored
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free
Sell
50
INCY
Incyte
Last Price:
$70.52
Seasonality Move:
-5.6%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock FreeIncyte Stock Forecast
-
Over the next 52 weeks, Incyte has on average historically risen by 29.1% based on the past 31 years of stock performance.
-
Incyte has risen higher in 20 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.52%
-
Is Incyte Stock Undervalued?The current Incyte [INCY] share price is $70.54. The Score for INCY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
INCY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Incyte Stock Go Up Next Year?
-
Over the next 52 weeks, Incyte has on average historically risen by 29.1% based on the past 31 years of stock performance.
Incyte Stock Rating
Sell
50
Incyte (INCY)
is a Sell
Is Incyte overpriced?
-
Incyte has risen higher in 20 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.52%
Incyte Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
incyte.com
52-Week Data
52-Week High:
83.95
52-Week Low:
50.35
Prediction Charts
Market Cap:
13.6B
Price in USD:
70.54
Volume:
1.9M
Beta:
1.40
Technical Analysis
SMA50:
73.33
SMA100:
69.20
SMA200:
64.00
52-Wk Change:
9.98%
Stock Predictions
-
Is Incyte stock public?Yes, Incyte is a publicly traded company.
-
What is the Incyte stock quote today?The Incyte stock price is 70.54 USD today.
-
How to buy Incyte stock online?You can buy Incyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-19 | 68.64 | 67.06 | 68.64 | 66.33 |
Dec-20 | 66.89 | 68.91 | 69.11 | 66.89 |
Dec-23 | 68.58 | 69.84 | 70.19 | 68.15 |
Dec-24 | 69.88 | 69.91 | 70.10 | 68.92 |
Dec-26 | 69.52 | 69.56 | 70.12 | 69.25 |
Dec-27 | 68.71 | 69.23 | 69.90 | 68.19 |
Dec-30 | 68.56 | 68.42 | 68.87 | 67.70 |
Dec-31 | 68.54 | 69.07 | 69.20 | 68.19 |
Jan-2 | 69.67 | 69.53 | 70.27 | 68.92 |
Jan-3 | 69.76 | 69.63 | 70.44 | 69.35 |
Jan-6 | 69.45 | 71.91 | 72.79 | 69.45 |
Jan-7 | 73.06 | 73.19 | 75.04 | 72.46 |
Jan-8 | 73.19 | 73.13 | 74.01 | 72.85 |
Jan-10 | 72.21 | 70.54 | 72.60 | 69.53 |
Incyte Earnings
Incyte Earnings Report: Per Share Incyte Earnings Q1 Q2 Q3 and Q4 last year and next year.
Incyte Forecast Revenue Growth
Incyte Stock Analysis: Historical quarterly revenues per share for Incyte and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.78 per share, and an increase next year of $1.68 per share.
* Incyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.